Cargando…
MAVS is not a Likely Susceptibility Locus for Addison’s Disease and Type 1 Diabetes
Mitochondrial antiviral signaling (MAVS) protein is an intracellular adaptor molecule, downstream of viral sensors, retinoid acid-inducible gene I (RIG-I)-like receptors (RLRs). Impaired antiviral cell signaling might contribute to autoimmunity. Studies have recently shown variations in genes encodi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434126/ https://www.ncbi.nlm.nih.gov/pubmed/27652379 http://dx.doi.org/10.1007/s00005-016-0426-6 |
_version_ | 1783236978668470272 |
---|---|
author | Zurawek, Magdalena Fichna, Marta Kazimierska, Marta Fichna, Piotr Dzikiewicz-Krawczyk, Agnieszka Przybylski, Grzegorz Ruchala, Marek Nowak, Jerzy |
author_facet | Zurawek, Magdalena Fichna, Marta Kazimierska, Marta Fichna, Piotr Dzikiewicz-Krawczyk, Agnieszka Przybylski, Grzegorz Ruchala, Marek Nowak, Jerzy |
author_sort | Zurawek, Magdalena |
collection | PubMed |
description | Mitochondrial antiviral signaling (MAVS) protein is an intracellular adaptor molecule, downstream of viral sensors, retinoid acid-inducible gene I (RIG-I)-like receptors (RLRs). Impaired antiviral cell signaling might contribute to autoimmunity. Studies have recently shown variations in genes encoding RLRs as risk factors for autoimmune diseases. We investigated whether MAVS coding polymorphisms are associated with Addison’s disease (AD) and type 1 diabetes (T1D) in Polish population. We genotyped 140 AD, 532 T1D patients and 600 healthy controls for MAVS rs17857295, rs7262903, rs45437096 and rs7269320. Genotyping was performed by TaqMan assays. Distribution of the MAVS genotypes and alleles did not reveal significant differences between patients and controls (p > 0.05). This analysis did not indicate the association of the MAVS locus with susceptibility to AD and T1D. |
format | Online Article Text |
id | pubmed-5434126 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-54341262017-05-31 MAVS is not a Likely Susceptibility Locus for Addison’s Disease and Type 1 Diabetes Zurawek, Magdalena Fichna, Marta Kazimierska, Marta Fichna, Piotr Dzikiewicz-Krawczyk, Agnieszka Przybylski, Grzegorz Ruchala, Marek Nowak, Jerzy Arch Immunol Ther Exp (Warsz) Short Communication Mitochondrial antiviral signaling (MAVS) protein is an intracellular adaptor molecule, downstream of viral sensors, retinoid acid-inducible gene I (RIG-I)-like receptors (RLRs). Impaired antiviral cell signaling might contribute to autoimmunity. Studies have recently shown variations in genes encoding RLRs as risk factors for autoimmune diseases. We investigated whether MAVS coding polymorphisms are associated with Addison’s disease (AD) and type 1 diabetes (T1D) in Polish population. We genotyped 140 AD, 532 T1D patients and 600 healthy controls for MAVS rs17857295, rs7262903, rs45437096 and rs7269320. Genotyping was performed by TaqMan assays. Distribution of the MAVS genotypes and alleles did not reveal significant differences between patients and controls (p > 0.05). This analysis did not indicate the association of the MAVS locus with susceptibility to AD and T1D. Springer International Publishing 2016-09-20 2017 /pmc/articles/PMC5434126/ /pubmed/27652379 http://dx.doi.org/10.1007/s00005-016-0426-6 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Short Communication Zurawek, Magdalena Fichna, Marta Kazimierska, Marta Fichna, Piotr Dzikiewicz-Krawczyk, Agnieszka Przybylski, Grzegorz Ruchala, Marek Nowak, Jerzy MAVS is not a Likely Susceptibility Locus for Addison’s Disease and Type 1 Diabetes |
title | MAVS is not a Likely Susceptibility Locus for Addison’s Disease and Type 1 Diabetes |
title_full | MAVS is not a Likely Susceptibility Locus for Addison’s Disease and Type 1 Diabetes |
title_fullStr | MAVS is not a Likely Susceptibility Locus for Addison’s Disease and Type 1 Diabetes |
title_full_unstemmed | MAVS is not a Likely Susceptibility Locus for Addison’s Disease and Type 1 Diabetes |
title_short | MAVS is not a Likely Susceptibility Locus for Addison’s Disease and Type 1 Diabetes |
title_sort | mavs is not a likely susceptibility locus for addison’s disease and type 1 diabetes |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434126/ https://www.ncbi.nlm.nih.gov/pubmed/27652379 http://dx.doi.org/10.1007/s00005-016-0426-6 |
work_keys_str_mv | AT zurawekmagdalena mavsisnotalikelysusceptibilitylocusforaddisonsdiseaseandtype1diabetes AT fichnamarta mavsisnotalikelysusceptibilitylocusforaddisonsdiseaseandtype1diabetes AT kazimierskamarta mavsisnotalikelysusceptibilitylocusforaddisonsdiseaseandtype1diabetes AT fichnapiotr mavsisnotalikelysusceptibilitylocusforaddisonsdiseaseandtype1diabetes AT dzikiewiczkrawczykagnieszka mavsisnotalikelysusceptibilitylocusforaddisonsdiseaseandtype1diabetes AT przybylskigrzegorz mavsisnotalikelysusceptibilitylocusforaddisonsdiseaseandtype1diabetes AT ruchalamarek mavsisnotalikelysusceptibilitylocusforaddisonsdiseaseandtype1diabetes AT nowakjerzy mavsisnotalikelysusceptibilitylocusforaddisonsdiseaseandtype1diabetes |